QRG Capital Management Inc. trimmed its position in CVS Health Co. (NYSE:CVS – Free Report) by 0.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 136,044 shares of the pharmacy operator’s stock after selling 632 shares during the quarter. QRG Capital Management Inc.’s holdings in CVS Health were worth $8,035,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the business. Wedmont Private Capital grew its stake in shares of CVS Health by 0.8% during the first quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock worth $1,410,000 after purchasing an additional 146 shares during the period. Bank of Stockton increased its stake in shares of CVS Health by 4.5% in the 1st quarter. Bank of Stockton now owns 3,467 shares of the pharmacy operator’s stock valued at $277,000 after acquiring an additional 150 shares during the last quarter. Moody National Bank Trust Division raised its position in shares of CVS Health by 0.7% in the 1st quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock valued at $1,776,000 after acquiring an additional 150 shares during the period. Landmark Financial Advisors LLC grew its holdings in CVS Health by 3.8% during the fourth quarter. Landmark Financial Advisors LLC now owns 4,166 shares of the pharmacy operator’s stock valued at $329,000 after purchasing an additional 153 shares during the period. Finally, Sepio Capital LP increased its stake in CVS Health by 1.7% in the fourth quarter. Sepio Capital LP now owns 9,907 shares of the pharmacy operator’s stock valued at $782,000 after purchasing an additional 163 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.
CVS Health Stock Down 1.3 %
Shares of NYSE:CVS traded down $0.74 during midday trading on Friday, hitting $57.11. The stock had a trading volume of 8,345,205 shares, compared to its average volume of 11,546,901. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78. The business’s 50-day simple moving average is $59.45 and its 200-day simple moving average is $66.19. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a market cap of $71.69 billion, a P/E ratio of 10.04, a PEG ratio of 0.57 and a beta of 0.52.
CVS Health Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.66%. CVS Health’s dividend payout ratio is currently 46.75%.
Analysts Set New Price Targets
CVS has been the subject of several research analyst reports. UBS Group lowered shares of CVS Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $85.00 to $60.00 in a report on Thursday, May 2nd. TD Cowen lowered CVS Health from a “buy” rating to a “hold” rating and dropped their price target for the stock from $99.00 to $59.00 in a research report on Tuesday, May 7th. Evercore ISI lowered their target price on CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research note on Thursday. JPMorgan Chase & Co. cut their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research note on Thursday, May 30th. Finally, Argus lowered their price objective on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, May 8th. Twelve research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $73.19.
Check Out Our Latest Research Report on CVS
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
- Five stocks we like better than CVS Health
- Bank Stocks – Best Bank Stocks to Invest In
- MarketBeat Week in Review – 8/5 – 8/9
- Options Trading – Understanding Strike Price
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- The Cannabis Sector: Profitability Takes Center Stage
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.